Biologics Anchoring Study

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 16, 2017

Study Completion Date

July 1, 2017

Conditions
Moderate-to-severe Psoriasis
Interventions
BEHAVIORAL

Control Group Oral Survey 1

Oral survey 1 will be administered as control intervention: patients will be asked how willing they would be to take an injectable medication to control their psoriasis which required once-monthly injections

BEHAVIORAL

Intervention Group Oral Survey 2

Oral Survey 2 will be administered as the intervention: patients will be asked how willing they would be to take an injectable medication to control their psoriasis which required once-daily injections, then surveyor would ask how willing they would be to take an injectable medication which required only once-monthly injections

Trial Locations (1)

27157

Dept of Dermatology, WFUHS, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03026153 - Biologics Anchoring Study | Biotech Hunter | Biotech Hunter